NAD(P)H-dependent oxidoreductase [Scardovia inopinata]
List of domain hits
Name | Accession | Description | Interval | E-value | ||
MdaB super family | cl43659 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
2-34 | 4.41e-08 | ||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; The actual alignment was detected with superfamily member COG2249: Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 46.37 E-value: 4.41e-08
|
||||||
Name | Accession | Description | Interval | E-value | ||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
2-34 | 4.41e-08 | ||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 46.37 E-value: 4.41e-08
|
||||||
PRK09739 | PRK09739 | NAD(P)H oxidoreductase; |
2-34 | 3.65e-06 | ||
NAD(P)H oxidoreductase; Pssm-ID: 236620 [Multi-domain] Cd Length: 199 Bit Score: 41.23 E-value: 3.65e-06
|
||||||
Flavodoxin_2 | pfam02525 | Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
13-34 | 2.18e-05 | ||
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258. Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 38.85 E-value: 2.18e-05
|
||||||
Name | Accession | Description | Interval | E-value | ||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
2-34 | 4.41e-08 | ||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 46.37 E-value: 4.41e-08
|
||||||
PRK09739 | PRK09739 | NAD(P)H oxidoreductase; |
2-34 | 3.65e-06 | ||
NAD(P)H oxidoreductase; Pssm-ID: 236620 [Multi-domain] Cd Length: 199 Bit Score: 41.23 E-value: 3.65e-06
|
||||||
Flavodoxin_2 | pfam02525 | Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
13-34 | 2.18e-05 | ||
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258. Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 38.85 E-value: 2.18e-05
|
||||||
Blast search parameters | ||||
|